skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
PI3Ka/mTOR Inhibitor PKI-179 (Code C90291)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: PI3Ka/mTOR Inhibitor PKI-179

Definition: A second generation, small-molecule mimetic of ATP that targets the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. PKI-179 selectively inhibits mTOR and phosphoinositide-3-kinase (PI3K) alpha. By inhibiting the PI3K/mTOR signaling pathway, this agent may inhibit tumor cell proliferation and survival.

Label: PI3Ka/mTOR Inhibitor PKI-179

NCI Thesaurus Code: C90291 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C2933673  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
PI3Ka/mTOR Inhibitor PKI-179

External Source Codes: 
FDA UNII Code CNN7Y60164
PDQ Closed Trial Search ID 658412
PDQ Open Trial Search ID 658412 (check for NCI PDQ open clinical trial info)
UMLS CUI C2933673

Other Properties:
     Name Value (qualifiers indented underneath)
code C90291
Contributing_Source FDA
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom